Search

Your search keyword '"Connolly, Lisa"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Connolly, Lisa" Remove constraint Author: "Connolly, Lisa" Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
36 results on '"Connolly, Lisa"'

Search Results

9. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

14. Cytotoxic assessment of the regulated, co-existing mycotoxins aflatoxin B1, fumonisin B1 and ochratoxin, in single, binary and tertiary mixtures.

15. The insulin-like growth factor system: A target for endocrine disruptors?

16. Effects of the mycotoxin patulin at the level of nuclear receptor transcriptional activity and steroidogenesis in vitro.

17. A human relevant mixture of persistent organic pollutants (POPs) and perfluorooctane sulfonic acid (PFOS) enhance nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.

18. The effect of individual and mixtures of mycotoxins and persistent organochloride pesticides on oestrogen receptor transcriptional activation using in vitro reporter gene assays.

19. The origin of in-vitro estrogen-like activity in oregano herb extracts.

20. In vitro bioassay investigations of suspected obesogen monosodium glutamate at the level of nuclear receptor binding and steroidogenesis.

21. The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction.

22. An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin.

23. In vitro bioassay investigations of the endocrine disrupting potential of steviol glycosides and their metabolite steviol, components of the natural sweetener Stevia.

24. Do persistent organic pollutants interact with the stress response? Individual compounds, and their mixtures, interaction with the glucocorticoid receptor.

25. Biotransformation of zearalenone and zearalenols to their major glucuronide metabolites reduces estrogenic activity.

26. An investigation of the endocrine disrupting potential of enniatin B using in vitro bioassays.

27. Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015].

28. Estrogenic endocrine disruptors present in sports supplements. A risk assessment for human health.

29. Obesity II: Establishing causal links between chemical exposures and obesity.

30. Endocrine disruptor activity in bottled mineral and flavoured water

31. Production of a monoclonal antibody and its application in an optical biosensor based assay for the quantitative measurement of pantothenic acid (vitamin B5) in foodstuffs

32. Treatment of estrogens and androgens in dairy wastewater by a constructed wetland system

33. Cytosol protein regulation in H295R steroidogenesis model induced by the zearalenone metabolites, α- and β-zearalenol

34. Relative quantification of the proteomic changes associated with the mycotoxin zearalenone in the H295R steroidogenesis model

35. Development of a monoclonal antibody binding okadaic acid and dinophysistoxins-1, -2 in proportion to their toxicity equivalence factors

36. Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation.

Catalog

Books, media, physical & digital resources